Research Output per year
Fingerprint Dive into the research topics where Phoebe Rich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Nails
Medicine & Life Sciences
Onychomycosis
Medicine & Life Sciences
Psoriasis
Medicine & Life Sciences
terbinafine
Medicine & Life Sciences
Nail Diseases
Medicine & Life Sciences
Safety
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Placebos
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1982 2019
Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial
Elewski, B. E., Baker, C. S., Crowley, J. J., Poulin, Y., Okun, M. M., Calimlim, B., Geng, Z., Reyes Servin, O. & Rich, P., Jan 1 2019, (Accepted/In press) In : Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Article
Open Access
Nails
Psoriasis
Randomized Controlled Trials
Placebos
Safety
A Randomized, Vehicle-Controlled Phase 3 Study of Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses on the Upper Extremities
Brian Jiang, S. I., Kempers, S., Rich, P., Marcus, S., Houlihan, A., Piacquadio, D. & Pariser, D., Jul 1 2019, In : Dermatologic Surgery. 45, 7, p. 890-897 8 p.Research output: Contribution to journal › Article
Actinic Keratosis
Aminolevulinic Acid
Photochemotherapy
Upper Extremity
Occlusive Dressings
Conservative Treatment of Retronychia: A Retrospective Study of 25 Patients
Laird, M. E., Lo Sicco, K. I. & Rich, P., Apr 1 2019, In : Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 45, 4, p. 614-616 3 p.Research output: Contribution to journal › Article
Retrospective Studies
Conservative Treatment
6
Citations
(Scopus)
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study
the AMAF investigators, Jan 1 2019, In : British Journal of Dermatology.Research output: Contribution to journal › Article
Psoriasis
Safety
Placebos
Interleukin-23
Therapeutics
Immunohistochemical characterization of benign activation of junctional melanocytes and melanoma in situ of the nail unit
Chu, A., André, J., Rich, P., Leachman, S. & Thompson, C. T., Jan 1 2019, In : Journal of cutaneous pathology.Research output: Contribution to journal › Article
Melanocytes
MART-1 Antigen
Nails
Melanoma
Coloring Agents